JP2025072440A5 - - Google Patents

Info

Publication number
JP2025072440A5
JP2025072440A5 JP2025014698A JP2025014698A JP2025072440A5 JP 2025072440 A5 JP2025072440 A5 JP 2025072440A5 JP 2025014698 A JP2025014698 A JP 2025014698A JP 2025014698 A JP2025014698 A JP 2025014698A JP 2025072440 A5 JP2025072440 A5 JP 2025072440A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
antigen
antibody
binding fragment
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025014698A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025072440A (ja
Filing date
Publication date
Priority claimed from JP2023560003A external-priority patent/JP7630012B2/ja
Application filed filed Critical
Publication of JP2025072440A publication Critical patent/JP2025072440A/ja
Publication of JP2025072440A5 publication Critical patent/JP2025072440A5/ja
Pending legal-status Critical Current

Links

JP2025014698A 2022-04-06 2025-01-31 Ｉｌ－６ｒアンタゴニストを投与することによってリウマチ性多発筋痛症を処置するための組成物および方法 Pending JP2025072440A (ja)

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
US202263327850P 2022-04-06 2022-04-06
US63/327,850 2022-04-06
US202263350761P 2022-06-09 2022-06-09
US63/350,761 2022-06-09
US202263389317P 2022-07-14 2022-07-14
US63/389,317 2022-07-14
US202263424035P 2022-11-09 2022-11-09
US63/424,035 2022-11-09
US202263424627P 2022-11-11 2022-11-11
US63/424,627 2022-11-11
US202363445331P 2023-02-14 2023-02-14
US202363445329P 2023-02-14 2023-02-14
US63/445,329 2023-02-14
US63/445,331 2023-02-14
US202363447796P 2023-02-23 2023-02-23
US63/447,796 2023-02-23
JP2023560003A JP7630012B2 (ja) 2022-04-06 2023-04-05 Ｉｌ－６ｒアンタゴニストを投与することによってリウマチ性多発筋痛症を処置するための組成物および方法
PCT/US2023/065361 WO2023196838A1 (en) 2022-04-06 2023-04-05 Compositions and methods for treating polymyalgia rheumatica by administering an il‑6r antagonist

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023560003A Division JP7630012B2 (ja) 2022-04-06 2023-04-05 Ｉｌ－６ｒアンタゴニストを投与することによってリウマチ性多発筋痛症を処置するための組成物および方法

Publications (2)

Publication Number Publication Date
JP2025072440A JP2025072440A (ja) 2025-05-09
JP2025072440A5 true JP2025072440A5 (https=) 2025-07-23

Family

ID=86424726

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023560003A Active JP7630012B2 (ja) 2022-04-06 2023-04-05 Ｉｌ－６ｒアンタゴニストを投与することによってリウマチ性多発筋痛症を処置するための組成物および方法
JP2025014698A Pending JP2025072440A (ja) 2022-04-06 2025-01-31 Ｉｌ－６ｒアンタゴニストを投与することによってリウマチ性多発筋痛症を処置するための組成物および方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2023560003A Active JP7630012B2 (ja) 2022-04-06 2023-04-05 Ｉｌ－６ｒアンタゴニストを投与することによってリウマチ性多発筋痛症を処置するための組成物および方法

Country Status (11)

Country Link
US (1) US20230399410A1 (https=)
EP (1) EP4504788A1 (https=)
JP (2) JP7630012B2 (https=)
KR (1) KR20240164816A (https=)
CN (1) CN120569404A (https=)
AU (1) AU2023250653A1 (https=)
CA (1) CA3247400A1 (https=)
IL (1) IL316091A (https=)
MX (1) MX2024012345A (https=)
TW (1) TW202405014A (https=)
WO (1) WO2023196838A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025149845A1 (en) * 2024-01-12 2025-07-17 Sanofi Biotechnology Treatment of subjects with polymyalgia rheumatica who have been receiving a steroid
WO2025149846A1 (en) * 2024-01-12 2025-07-17 Sanofi Biotechnology Compositions and methods for treating frail subjects with polymyalgia rheumatica by administering an il-6r antagonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2398076T3 (es) * 2006-06-02 2013-03-13 Regeneron Pharmaceuticals, Inc. Anticuerpos de alta afinidad contra el receptor de IL-6 humano
WO2017106312A1 (en) * 2015-12-18 2017-06-22 Drexel University Methods of modulating levels of il-6 and pd-l1
EP3980459A1 (en) * 2019-06-04 2022-04-13 Sanofi Biotechnology Compositions and methods for treating pain in subj ects with rheumatoid arthritis

Similar Documents

Publication Publication Date Title
JP2025072440A5 (https=)
JP2025172841A5 (https=)
JP2019531273A5 (https=)
RU2016136364A (ru) Способы лечения или предупреждения астмы посредством введения антагониста il-4r
CN110624107A (zh) 通过施用il-4r拮抗剂治疗或预防哮喘的方法
JP2022160685A5 (https=)
JP2022523530A (ja) 化膿性汗腺炎の治療のための抗ＩＬ－α抗体
US20200231666A1 (en) Treatment paradigm
KR20180017145A (ko) 소양증의 치료
AU2020377872A1 (en) Treatment for Sjogren's Syndrome
TW202110892A (zh) 治療具有類風濕性關節炎的個體中疼痛之組成物及方法
JP2021533142A5 (https=)
US20240425577A1 (en) Pan-elr+ cxc chemokine antibodies for the treatment of hidradenitis suppurativa
JP2024517796A (ja) 抗ｂａｆｆｒ抗体を使用するループス腎炎の治療
WO2021018191A1 (zh) Il-17拮抗剂治疗自身免疫疾病的方法
WO2026060205A1 (en) PAN-ELR+ CXC CHEMOKINE ANTIBODIES AND IL-23p19 ANTIBODIES FOR THE TREATMENT OF ULCERATIVE COLITIS
JPWO2022235758A5 (https=)
JPWO2020247461A5 (https=)
JPWO2020215019A5 (https=)
RU2024129441A (ru) Композиции и способы для лечения ревматической полимиалгии путем введения антагониста il-6r
WO2025257781A1 (en) Treatment of systemic sclerosis using anti-baff-r antibodies
RU2021138376A (ru) Композиции и способы лечения боли у субъектов с ревматоидным артритом
WO2024077113A1 (en) Methods of treating fatigue in ulcerative colitis
RU2024121393A (ru) Способы ослабления атопического марша посредством введения антагониста il-4/il-13
IL323041A (en) Methods for treating ulcerative colitis